What is KPV?
KPV is a very small peptide made of three amino acids: lysine, proline and valine. That sequence forms the end of alpha-melanocyte-stimulating hormone, or alpha-MSH, a 13-amino-acid hormone known for its role in skin pigment and in calming inflammation. In the 1980s and 1990s, researchers found that this short end piece kept some of alpha-MSH's anti-inflammatory activity in experiments.
The KPV studied in labs is made synthetically. It is often described online as naturally produced, but that mainly means its sequence exists inside alpha-MSH. Unlike alpha-MSH itself, KPV is not generally thought to cause skin darkening, which is one reason researchers explored it as a possible anti-inflammatory compound.
How does KPV work?
In cell studies, KPV lowered activity of NF-kappa B, a protein complex that switches on many inflammatory genes, and reduced release of inflammatory signals such as TNF-alpha and certain interleukins. In intestinal cells, researchers reported that KPV is carried into the cell by PepT1, a transporter that normally moves small peptides from digested food. PepT1 levels rise in inflamed gut tissue, which may help explain its focus on gut research.
Some sources describe KPV as using nanoparticles to target inflammation. That refers to an experimental delivery method, in which researchers packed KPV into nanoparticles to reach the colon in mice. It is not something the peptide does on its own. Whether KPV acts through melanocortin receptors, other pathways or both is still debated.
What has research looked at?
- Colitis in mice
- In mouse models of colitis, researchers reported that KPV given in drinking water reduced inflammation and tissue damage in the colon. Nanoparticle forms aimed at the colon were reported to have similar effects in mice.
- Intestinal cells
- In human intestinal cell lines, KPV reduced inflammatory signaling, and its uptake through PepT1 was described.
- Skin inflammation
- Lab studies with skin cells and some animal work suggested KPV may dampen inflammatory responses in skin. These findings are early.
- Antimicrobial activity
- In lab dishes, alpha-MSH and KPV were reported to slow the growth of some microbes, including Staphylococcus aureus and Candida albicans. This has not been shown as a treatment in people.
- Wounds
- A small amount of animal and lab work has explored KPV in wound models. The evidence is limited and early.
No controlled human trials of KPV have been published. The findings that drive interest in it, mainly reduced colitis in mice, have not yet been tested in people with inflammatory bowel disease or any other condition. Mouse colitis models capture only part of human bowel disease, and results in them do not always carry over to people.
Side effects and cautions
Because KPV has not been studied in published human trials, its side effects in people are not known. Animal studies did not report major toxic effects, but that does not establish human safety. Effects people describe online, such as irritation where it was injected, nausea, digestive upset or tiredness, are anecdotal. Anyone with health questions should talk to a qualified clinician.
- Immune effects
- KPV is studied for dampening inflammatory signals. Inflammation is also part of fighting infection, and how KPV affects that balance in people is unknown.
- Existing conditions
- People with inflammatory bowel disease or autoimmune conditions have not been studied, even though these are the conditions KPV is most often discussed for.
- Long-term effects
- No study has followed people using KPV over time.
- Product content
- Peptides sold outside medical settings can differ from their labels in content or purity.
- Pregnancy and breastfeeding
- There are no safety data.
Further reading
This page summarizes the research in plain words. To read the studies yourself:
- Published studies on KPV PubMed, US National Library of Medicine
